ATXN8OS: A Potential Drug Target Or Biomarker (G6315)

Target Name: ATXN8OS

NCBI ID: G6315

ATXN8OS

Other Name(s): NCRNA00003 | KLHL1AS | SCA8 | ATXN8 opposite strand lncRNA

ATXN8OS: A Potential Drug Target Or Biomarker

ATXN8OS, also known as NCRNA00003, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and respiratory disorders.

ATXN8OS is a member of the non-coding RNA (ncRNA) family, which includes proteins that have the ability to interact with RNA molecules and regulate gene expression. It is characterized by its highly conserved structure and its ability to form a stable complex with certain RNA molecules.

One of the most promising aspects of ATXN8OS is its potential as a drug target. Its ability to interact with specific RNA molecules has led to the idea that it may be a target for small molecules or other therapeutic compounds that can modulate its activity. Additionally, its conserved structure suggests that it may be a good candidate for drug discovery, with potential applications in a range of therapeutic areas.

In addition to its potential as a drug target, ATXN8OS has also been identified as a potential biomarker for a variety of diseases. Its stability and conservation in the human genome make it a strong candidate for use as a biomarker for diseases that are difficult to diagnose or treat, such as cancer, neurodegenerative diseases, and respiratory disorders.

The identification of ATXN8OS as a potential drug target or biomarker has important implications for both research and clinical practice. The development of small molecules or other therapeutic compounds that can modulate ATXN8OS activity may lead to new treatments for a variety of diseases. Additionally, its potential as a biomarker for a range of diseases may have implications for the development of new diagnostic tests or therapies.

Overall, the potential of ATXN8OS as a drug target or biomarker is an exciting area of research that has the potential to lead to new treatments and therapies for a variety of diseases. Further studies are needed to fully understand its biology and develop its potential as a drug or biomarker.

Protein Name: ATXN8 Opposite Strand LncRNA

The "ATXN8OS Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATXN8OS comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets